SALT

Myriad Genetics Announces Pricing of Upsized Offering of Common Stock

Retrieved on: 
목요일, 11월 9, 2023

SALT LAKE CITY, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN) (the “Company” or “Myriad Genetics”), a leader in genetic testing and precision medicine, today announced the pricing of an upsized underwritten public offering of 6,470,588 shares of its common stock, par value $0.01 per share (“common stock”), at a public offering price of $17.00 per share for expected gross proceeds of approximately $110 million, before deducting the underwriting discounts and commissions and estimated offering expenses payable by the Company.

Key Points: 
  • SALT LAKE CITY, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN) (the “Company” or “Myriad Genetics”), a leader in genetic testing and precision medicine, today announced the pricing of an upsized underwritten public offering of 6,470,588 shares of its common stock, par value $0.01 per share (“common stock”), at a public offering price of $17.00 per share for expected gross proceeds of approximately $110 million, before deducting the underwriting discounts and commissions and estimated offering expenses payable by the Company.
  • The Company has also granted the underwriters a 30-day option to purchase up to an additional 970,588 shares of its common stock at the public offering price, less underwriting discounts and commissions.
  • All of the shares in the offering are to be sold by the Company.
  • Goldman Sachs & Co. LLC, Morgan Stanley and Wells Fargo Securities are acting as joint book-running managers for the offering.

Recursion Announces Data Collaboration Deal with Tempus, Top 50 Supercomputer Ambition Powered by NVIDIA, and Updated Focus of Collaboration with Bayer to Precision Oncology

Retrieved on: 
목요일, 11월 9, 2023

“Today, we are thrilled to share three major initiatives that support this belief and our mission to bring better medicines to patients at speed and scale.

Key Points: 
  • “Today, we are thrilled to share three major initiatives that support this belief and our mission to bring better medicines to patients at speed and scale.
  • By combining the forward genetics approach of Tempus with the reverse genetics approach at Recursion, the company believes it has an opportunity to improve the speed, precision and scale of therapeutic development in oncology.
  • “We share Recursion’s commitment to a data-first approach to precision medicine,” said Eric Lefkofsky, Founder and CEO of Tempus.
  • This decision allows Bayer to leverage Recursion’s state-of-the-art capabilities to identify novel targets and chemistry applicable to oncology indications.

Recursion Provides Business Updates and Reports Third Quarter 2023 Financial Results

Retrieved on: 
목요일, 11월 9, 2023

Revenue: Total revenue was $10.5 million for the third quarter of 2023, compared to $13.2 million for the third quarter of 2022.

Key Points: 
  • Revenue: Total revenue was $10.5 million for the third quarter of 2023, compared to $13.2 million for the third quarter of 2022.
  • General and Administrative Expenses: General and administrative expenses were $29.2 million for the third quarter of 2023, compared to $19.5 million for the third quarter of 2022.
  • Net Loss: Net loss was $93.0 million for the third quarter of 2023, compared to a net loss of $60.4 million for the third quarter of 2022.
  • Net Cash: Net cash used in operating activities was $72.9 million for the third quarter of 2023, compared to net cash used in operating activities of $54.5 million for the third quarter of 2022.

Myriad Genetics to Participate in Stephens Annual Investment Conference

Retrieved on: 
목요일, 11월 9, 2023

SALT LAKE CITY, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. , (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced Myriad management will participate in the Stephens Annual Investment Conference in Nashville, TN with a fireside chat on Wednesday, November 15 at 2:00 p.m.

Key Points: 
  • SALT LAKE CITY, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. , (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced Myriad management will participate in the Stephens Annual Investment Conference in Nashville, TN with a fireside chat on Wednesday, November 15 at 2:00 p.m.
  • ET.

Myriad Genetics Announces Proposed Offering of $100 Million of Shares of Common Stock

Retrieved on: 
수요일, 11월 8, 2023

SALT LAKE CITY, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN) (the “Company” or “Myriad Genetics”), a leader in genetic testing and precision medicine, today announced that it plans to make a public offering of $100.0 million of shares of its common stock, par value $0.01 per share (“common stock”), in an underwritten registered public offering.

Key Points: 
  • SALT LAKE CITY, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN) (the “Company” or “Myriad Genetics”), a leader in genetic testing and precision medicine, today announced that it plans to make a public offering of $100.0 million of shares of its common stock, par value $0.01 per share (“common stock”), in an underwritten registered public offering.
  • The Company also expects to grant the underwriters a 30-day option to purchase up to $15.0 million of additional shares of its common stock.
  • The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed or as to the final size or terms of the offering.
  • All of the shares in the proposed offering are to be sold by the Company.

Measured Analytics and Insurance Today Announced Its Latest White Paper, "How Generative AI Will Transform Cyber Insurance in the Next 24 Months"

Retrieved on: 
목요일, 11월 9, 2023

SALT LAKE CITY , Nov. 9, 2023 /PRNewswire/ -- Measured Analytics and Insurance (Measured AI), the AI-powered cyber insurance provider to small and midsize enterprises (SMEs), today announced the release of its leading-edge white paper, " How Generative AI Will Transform Cyber Insurance in the Next 24 Months ."

Key Points: 
  • SALT LAKE CITY , Nov. 9, 2023 /PRNewswire/ -- Measured Analytics and Insurance (Measured AI), the AI-powered cyber insurance provider to small and midsize enterprises (SMEs), today announced the release of its leading-edge white paper, " How Generative AI Will Transform Cyber Insurance in the Next 24 Months ."
  • Measured AI's research highlights the power of Generative AI to revolutionize cyber insurance, benefiting insurers, brokers, and customers.
  • Measured AI uniquely understands the extensive benefits and inherent risks of AI and is responsibly driving true value for our partners and customers."
  • "Generative AI is poised to reshape the cyber insurance industry, making it more efficient, responsive, and customer-centric," remarked Dr. Padmanabh Dabke, Chief Product Officer of Measured.

Everee Unveils Automated Payroll Powered by AI

Retrieved on: 
목요일, 11월 9, 2023

SALT LAKE CITY, Nov. 9, 2023 /PRNewswire/ -- Everee, a leading payroll technology company making it easy to pay workers instantly, today announced the launch of Auto Payroll, an AI-powered solution that fully automates payroll for both hourly and salaried employees. Auto Payroll is the company's latest addition to a suite of tools aimed at enabling businesses to implement faster pay for workers into their payroll processes.

Key Points: 
  • Auto Payroll is the company's latest addition to a suite of tools aimed at enabling businesses to implement faster pay for workers into their payroll processes.
  • "At Everee, we're not just trying to make payroll less painful, we want to take running payroll off a company's to-do list entirely," said Brett Barlow, Everee CEO.
  • "Using AI to automate payroll means companies that want to pay their employees quicker will actually have the bandwidth to do so with confidence.
  • "When we first started offering daily payroll, some people were skeptical about what it would take to process payroll daily.

Largest Edtech User Group, Instructure's Community, Celebrates 2 Million Member Milestone

Retrieved on: 
수요일, 11월 8, 2023

SALT LAKE CITY, Nov. 8, 2023 /PRNewswire/ -- Instructure (NYSE: INST), the leading learning platform and maker of Canvas, today celebrates a significant milestone as it welcomes the 2 millionth member of the Community, the online resource for global users of the Instructure Learning Platform.

Key Points: 
  • The Instructure Community, the largest global edtech community which averages more than 57 million page views annually, provides users with up-to-date, quality information and support as they learn about and implement the products in the Instructure Learning Platform like Canvas LMS , Mastery Connect , Impact , LearnPlatform and Elevate .
  • That information is disseminated through a variety of resources such as user guides, questions forums, blogs, online live events, product guides, release news, information hubs, interest groups and user "Unconferences" held annually during InstructureCon.
  • "Instructure highly values input from our incredibly engaged and passionate users and the product team thrives on the customer interaction.
  • "In 2023 alone, we have received more than 1,200 new customer-created ideas and 74 ideas have been featured in 2023 product releases."

Blue Owl AI Predicts Epic Games Monumental Fortnite OG Relaunch--and Says Data Shows Similar Opportunities for Other Game Publishers

Retrieved on: 
수요일, 11월 8, 2023

SALT LAKE CITY, Nov. 8, 2023 /PRNewswire/ -- Last week, Epic Games made history with the release of Fortnite OG.

Key Points: 
  • SALT LAKE CITY, Nov. 8, 2023 /PRNewswire/ -- Last week, Epic Games made history with the release of Fortnite OG.
  • According to predictive models based on gamer research by Blue Owl AI, other publishers could have similar uncaptured opportunities.
  • This week, Blue Owl AI shared examples of games released over a year ago that together show over $700 million in potential sales.
  • Blue Owl AI is committed to exploring new avenues and strategies with game publishers, setting the stage for even more groundbreaking achievements in the future.

Utah Ranks Among Fastest Growing Life Sciences Industries in the Nation

Retrieved on: 
수요일, 11월 8, 2023

The report is a comprehensive statewide and national industry analysis conducted by the Kem C. Gardner Policy Institute, which finds that Utah has one of the fastest growing industries in the nation.

Key Points: 
  • The report is a comprehensive statewide and national industry analysis conducted by the Kem C. Gardner Policy Institute, which finds that Utah has one of the fastest growing industries in the nation.
  • “With many high growth Life Sciences companies in Utah, the report findings are no surprise,” observed BioUtah CEO, Kelvyn Cullimore.
  • “Industry, academia, government, and health care delivery are collaborating to build a significant life sciences hub in Utah.
  • (Average is 3.5% in other states)
    Utah’s ranks third over the last decade among top 20 states with the largest life sciences employment growth.